tiprankstipranks
Trending News
More News >
Vir Biotechnology, Inc. (VIR)
:VIR
US Market
Advertisement

Vir Biotechnology (VIR) Similar Stocks

Compare
1,379 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Vir Biotechnology
$4.58
$636.24M
-47.78%
6 Buy
1 Hold
0 Sell
Strong Buy
Spyre Therapeutics
$17.38
$1.01B
2.31
-31.92%
7 Buy
1 Hold
0 Sell
Strong Buy
Intellia Therapeutics
$10.52
$1.09B
-55.48%
17 Buy
3 Hold
1 Sell
Strong Buy
Arcus Biosciences
$10.53
$1.12B
-41.53%
9 Buy
2 Hold
0 Sell
Strong Buy
Nurix Therapeutics
$10.14
$775.20M
-57.79%
11 Buy
3 Hold
0 Sell
Strong Buy
Pharvaris
$23.12
$1.50B
29.52%
7 Buy
0 Hold
1 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
VIR
Vir Biotechnology
4.58
-4.04
-46.87%
SYRE
Spyre Therapeutics
17.38
-9.61
-35.61%
NTLA
Intellia Therapeutics
10.52
-13.06
-55.39%
RCUS
Arcus Biosciences
10.53
-7.40
-41.27%
NRIX
Nurix Therapeutics
10.14
-15.55
-60.53%
PHVS
Pharvaris
23.12
4.04
21.17%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis